Egg Protein Hydrolysate and Vascular Function

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

November 30, 2013

Conditions
Arterial StiffnessDietary ModificationImpaired Glucose ToleranceType 2 Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

protein hydrolysate capsules and placebo capsules

Once in the study, 20 subjects will be randomly assigned to a group taking capsules containing 5 gr egg protein hydrolysate per day, and 20 to a group taking placebo capsules. The subjects consume the capsules during three consecutive days (period 1). Following a wash-out period of minimally four weeks, the treatments are crossed-over.

Trial Locations (1)

6191 JW

PreCare Trial & Recruitment, Beek

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT01559896 - Egg Protein Hydrolysate and Vascular Function | Biotech Hunter | Biotech Hunter